Post Acute Sequelae of COVID-19 Clinical Trials

7 recruitingLast updated: June 18, 2026

There are 7 actively recruiting post acute sequelae of covid-19 clinical trials across 2 countries. Studies span Not Applicable, Phase 1, Phase 2. Top locations include Toronto, Ontario, Canada, Boston, Massachusetts, United States, Edmonton, Alberta, Canada. Updated daily from ClinicalTrials.gov.


Post Acute Sequelae of COVID-19 Trials at a Glance

7 actively recruiting trials for post acute sequelae of covid-19 are listed on ClinicalTrialsFinder across 6 cities in 2 countries. The largest study group is Not Applicable with 4 trials, with the heaviest enrollment activity in Toronto, Boston, and Edmonton. Lead sponsors running post acute sequelae of covid-19 studies include University Health Network, Toronto, Beth Israel Deaconess Medical Center, and Massachusetts General Hospital.

Browse post acute sequelae of covid-19 trials by phase

Treatments under study

About Post Acute Sequelae of COVID-19 Clinical Trials

Looking for clinical trials for Post Acute Sequelae of COVID-19? There are currently 7 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Post Acute Sequelae of COVID-19 trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Post Acute Sequelae of COVID-19 clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting
Phase 1

PET Imaging of Cyclooxygenase-1 in Participants With Neurological Manifestations of Post-Acute Sequelae of SARS-CoV-2 Infection (PASC)

Post Acute Sequelae of COVID-19Long COVID
National Institute of Mental Health (NIMH)60 enrolled1 locationNCT06920628
Recruiting
Not Applicable

Autoimmune Intervention Mastery Course Study

Multiple SclerosisClinically Isolated SyndromeFibromyalgia+2 more
Terry L. Wahls400 enrolled1 locationNCT05057676
Recruiting
Not Applicable

Recovering From COVID-19 Lingering Symptoms Adaptive Integrative Medicine Trial - Effect of Hyperbaric Oxygen Therapy for the Treatment of Post COVID Condition

Post COVID-19 ConditionPost Acute Sequelae of COVID-19Long COVID
University Health Network, Toronto120 enrolled1 locationNCT06452095
Recruiting
Not Applicable

Mind Body Intervention for Long COVID-19

Post Acute Sequelae of COVID-19Long COVIDCOVID Long-Haul
Beth Israel Deaconess Medical Center180 enrolled1 locationNCT06045338
Recruiting
Not Applicable

Effect of Hi-OxSR for the Treatment of Post COVID Condition

Post COVID-19 ConditionPost Acute Sequelae of COVID-19Long COVID
University Health Network, Toronto120 enrolled3 locationsNCT06928506
Recruiting
Phase 2

AT1001 for the Treatment of Long COVID

Post-Acute COVID-19 SyndromePost Acute Sequelae of COVID-19Long COVID+1 more
Massachusetts General Hospital150 enrolled2 locationsNCT05747534
Recruiting

COVID-19 Outcome Prediction Algorithm

Frailty SyndromeCOVID-19Post Acute Sequelae of COVID-19+2 more
University of California, Los Angeles600 enrolled7 locationsNCT05471011